全球主動脈瘤市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計主動脈瘤市場將從 2025 年的 73.2 億美元成長到 2034 年的 121.8 億美元，2026 年至 2034 年的複合年成長率為 5.82%。

由於心血管疾病盛行率不斷上升以及人們對早期診斷意識提升，全球主動脈瘤市場正經歷穩定成長。主動脈瘤若不及時治療，可能導致嚴重的併發症，因此迫切需要有效的治療方法。 CT電腦斷層掃描和超音波等影像技術的進步提高了檢出率。此外，微創手術，例如血管內主動脈瘤修復術（EVAR），也越來越普及。

成長要素包括全球人口老化以及高血壓和吸菸等風險因素的增加。醫療服務提供者正致力於開展預防性篩檢項目，以識別高風險患者。外科手術設備、血管支架技術和醫院基礎設施的改進，促進了治療方法的普及。已開發國家和開發中國家醫療費用支出的成長，也進一步推動了市場發展。

預計未來成長將主要得益於創新醫療設備的研發和病患監測系統的改進。對更安全、更耐用的移植物材料的研究有望改善長期治療效果。新興市場先進療法的普及將創造新的機會。總體而言，血管治療和預防性篩檢的持續進步將塑造主動脈瘤市場的長期前景。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球主動脈瘤市場：依類型分類

• 市場分析、洞察與預測
• 胸主動脈瘤
• 腹部主動脈血管瘤
• 腹部主動脈血管瘤
• 頸主動脈瘤

第5章：全球主動脈瘤市場：依診斷方法分類

• 市場分析、洞察與預測
• 超音波
• 電腦斷層掃描
• MRI
• X光
• 血管造影術

第6章：全球主動脈瘤市場：依治療類型分類

• 市場分析、洞察與預測
• 手術修復
• 血管內動脈瘤修復術
• 藥物
• 監測

第7章 全球主動脈瘤市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 診斷檢查室
• 專科診所

第8章 全球主動脈瘤市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Sutas
  • Cook Medical
  • Abbott
  • Cypress Medical
  • Endologix
  • Boston Scientific
  • Phillips
  • Johnson & Johnson
  • Aptus Endosystems
  • Biotronik
  • Cardinal Health

The Aortic Aneurysm Market size is expected to reach USD 12.18 Billion in 2034 from USD 7.32 Billion (2025) growing at a CAGR of 5.82% during 2026-2034.

The Global Aortic Aneurysm Market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and increasing awareness about early diagnosis. Aortic aneurysms, if untreated, can lead to severe complications, creating a strong need for effective treatment options. Technological advancements in imaging techniques such as CT scans and ultrasound are improving detection rates. Minimally invasive procedures like endovascular aneurysm repair (EVAR) are also gaining popularity.

Key drivers include the aging global population and growing risk factors such as hypertension and smoking. Healthcare providers are focusing on preventive screening programs to identify high-risk patients. Improvements in surgical devices, stent graft technologies, and hospital infrastructure are supporting treatment adoption. Increased healthcare spending in both developed and developing countries is further boosting the market.

Future growth is expected to be supported by innovative device development and better patient monitoring systems. Research into safer and more durable graft materials may improve long-term outcomes. Expanding access to advanced treatment in emerging markets will create new opportunities. Overall, ongoing advancements in vascular care and preventive screening will shape the long-term outlook of the Aortic Aneurysm Market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Thoracic Aortic Aneurysm
• Abdominal Aortic Aneurysm
• Thoracoabdominal Aortic Aneurysm
• Cervical Aortic Aneurysm

By Diagnosis Method

• Ultrasound
• CT Scan
• MRI
• X-Ray
• Angiography

By Treatment Type

• Surgical Repair
• Endovascular Aneurysm Repair
• Medication
• Monitoring

By End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Specialty Clinics

COMPANIES PROFILED

• Sutas, Cook Medical, Abbott, Cypress Medical, Endologix, Boston Scientific, Phillips, Johnson Johnson, Aptus Endosystems, Biotronik, Cardinal Health
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL AORTIC ANEURYSM MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Thoracic Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Abdominal Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Thoracoabdominal Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Cervical Aortic Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AORTIC ANEURYSM MARKET: BY DIAGNOSIS METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosis Method
• 5.2. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. CT Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. MRI Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. X-Ray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Angiography Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AORTIC ANEURYSM MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Treatment Type
• 6.2. Surgical Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Endovascular Aneurysm Repair Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AORTIC ANEURYSM MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AORTIC ANEURYSM MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Diagnosis Method
  • 8.2.3 By Treatment Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Diagnosis Method
  • 8.3.3 By Treatment Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Diagnosis Method
  • 8.4.3 By Treatment Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Diagnosis Method
  • 8.5.3 By Treatment Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Diagnosis Method
  • 8.6.3 By Treatment Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AORTIC ANEURYSM INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Sutas
  • 10.2.2 Cook Medical
  • 10.2.3 Abbott
  • 10.2.4 Cypress Medical
  • 10.2.5 Endologix
  • 10.2.6 Boston Scientific
  • 10.2.7 Phillips
  • 10.2.8 Johnson & Johnson
  • 10.2.9 Aptus Endosystems
  • 10.2.10 Biotronik
  • 10.2.11 Cardinal Health